Susquehanna International Group
SWTX

Susquehanna International Group’s SpringWorks Therapeutics SWTX Stock Holding History

Susquehanna International Group’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-726,700
Closed -$34.1M – 13831
2025
Q2 		$34.1M Sell
726,700
-237,400
-25% -$10.6M ﹤0.01% 1482
2025
Q1 		$42.5M Buy
964,100
+856,800
+799% +$39.4M 0.01% 1123
2024
Q4 		$3.88M Sell
107,300
-1,900
-2% -$66.4K ﹤0.01% 4004
2024
Q3 		$3.5M Buy
109,200
+1,300
+1% +$48.6K ﹤0.01% 4264
2024
Q2 		$4.06M Buy
107,900
+91,300
+550% +$3.84M ﹤0.01% 3790
2024
Q1 		$817K Sell
16,600
-29,900
-64% -$1.38M ﹤0.01% 7365
2023
Q4 		$1.7M Buy
46,500
+36,900
+384% +$963K ﹤0.01% 5709
2023
Q3 		$222K Sell
9,600
-22,500
-70% -$615K ﹤0.01% 10010
2023
Q2 		$842K Buy
+32,100
New +$844K ﹤0.01% 7091
2023
Q1 		– Sell
-18,900
Closed -$492K – 13475
2022
Q4 		$492K Buy
18,900
+4,500
+31% +$111K ﹤0.01% 7911
2022
Q3 		$411K Buy
+14,400
New +$413K ﹤0.01% 8996
2022
Q2 		– Sell
-60,400
Closed -$3.41M – 13910
2022
Q1 		$3.41M Buy
60,400
+56,300
+1,373% +$3.22M ﹤0.01% 4381
2021
Q4 		$254K Buy
4,100
+400
+11% +$26.5K ﹤0.01% 10895
2021
Q3 		$235K Buy
3,700
+1,000
+37% +$77.1K ﹤0.01% 11141
2021
Q2 		$223K Buy
+2,700
New +$205K ﹤0.01% 11370

Other funds holding SWTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's SWTX Position: Q3 2025 in Review

Susquehanna International Group sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 484,874 shares — an estimated $22.8M sold.

Susquehanna International Group first reported a position in SWTX in Q3 2019 and held it in 20 quarters. The position peaked at $27.5M in Q1 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

  • Susquehanna International Group reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 484,874 SpringWorks Therapeutics shares in Q3 2025, an estimated $22.8M.
  • Susquehanna International Group first reported a position in SpringWorks Therapeutics in Q3 2019 and held it in 20 quarters.
  • Susquehanna International Group's SpringWorks Therapeutics position peaked at $27.5M in Q1 2025.
  • 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.